Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : Nvax    crawled time : 01:00    save search

Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine
Published: 2022-01-19 (Crawled : 01:00) - prnewswire.com
NVAX | $3.98 2.31% 640K twitter stocktwits trandingview |
Health Technology
| | O: 2.59% H: 3.89% C: -4.6%

covid-19 covid tga australia vaccine granted grant
Novavax and SK bioscience Expand Manufacturing Agreement
Published: 2021-12-23 (Crawled : 01:00) - prnewswire.com
NVAX | $3.98 2.31% 640K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

bioscience expansion
CLAIMSFILER ALERTS NOVAVAX Investors to Lead Plaintiff Deadline in Class Action Lawsuit Against Novavax, Inc. - NVAX
Published: 2021-12-02 (Crawled : 01:00) - prnewswire.com
NVAX | $3.98 2.31% 640K twitter stocktwits trandingview |
Health Technology
| | O: -6.87% H: 3.23% C: -11.49%

deadline
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases
Published: 2021-09-24 (Crawled : 01:00) - prnewswire.com
NVAX | $3.98 2.31% 640K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: 0.0%

disease infectious disease results vaccine influenza phase 3 trial lancet
New England Journal of Medicine Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
NVAX | $3.98 2.31% 640K twitter stocktwits trandingview |
Health Technology
| | O: 3.47% H: 4.31% C: -8.13%

covid phase 2 results vaccine phase 2b trial trial results
Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science
Published: 2021-02-02 (Crawled : 01:00) - globenewswire.com
NVAX | $3.98 2.31% 640K twitter stocktwits trandingview |
Health Technology
| | O: 0.44% H: 0.86% C: -1.88%

covid vaccine covid-19
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine
Published: 2020-12-17 (Crawled : 01:00) - globenewswire.com
NVAX | $3.98 2.31% 640K twitter stocktwits trandingview |
Health Technology
| | O: 2.98% H: 6.57% C: 5.84%

vaccine covid covid-19
Gainers vs Losers
79% 21%

Top 10 Gainers
AGBA | News | $1.22 205.0% 86M twitter stocktwits trandingview |
Finance

EGOX | $0.0606 68.33% 250M twitter stocktwits trandingview |

NVFY | $3.45 63.51% 20M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.98 36.55% 27M twitter stocktwits trandingview |
Commercial Services

CHRO | $1.66 35.51% 70K twitter stocktwits trandingview |
n/a

INDO | $5.43 33.09% 10M twitter stocktwits trandingview |
Energy Minerals

PAPL | $2.07 26.22% 550K twitter stocktwits trandingview |

RWOD | $10.08 26.05% 5.6M twitter stocktwits trandingview |
n/a

AULT | $0.304 25.57% 47M twitter stocktwits trandingview |
Manufacturing

HUSA 4 | $2.07 23.95% 2.1M twitter stocktwits trandingview |
Energy Minerals


Your saved searches
Save your searches and get alerts when important news are released.